Wyeth Pharmaceuticals

Huntercombe Lane South, Taplow, Maidenhead, Berks, SL6 0PH
Telephone: +44 (0)1628 604 377
Fax: +44 (0)1628 666 368
Medical Information Direct Line: +44 (0)845 367 0098
Medical Information e-mail: ukmedinfo@wyeth.com
Medical Information Fax: +44 (0)845 367 0777
Patient Information Leaflet last updated on the eMC: 27/01/2009
PIL EFEXOR XL 150mg CAPSULES

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 27/01/2009 and displayed until Current
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Addition of separate PILs covering individual presentations
  • Change due to user-testing of patient information
Updated on 22/05/2008 and displayed until 27/01/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 26/04/2007 and displayed until 22/05/2008
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 21/12/2006 and displayed until 26/04/2007
Reasons for adding or updating:
  • Change of contra-indications
  • Change to date of revision
  • Correction of spelling/typing errors
Updated on 22/06/2006 and displayed until 21/12/2006
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change of contra-indications
  • Change to instructions about overdose
  • Change to drug interactions
  • Change to information about pregnancy or lactation
  • Change to how the medicine works
  • Change to side-effects
  • Change to date of revision
Updated on 09/08/2005 and displayed until 22/06/2006
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 05/08/2005 and displayed until 09/08/2005
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to how to administer the medicine
Updated on 22/12/2003 and displayed until 05/08/2005
Reasons for adding or updating:
  • Update to PIL
Updated on 19/05/2003 and displayed until 22/12/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 13/12/2002 and displayed until 19/05/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 03/04/2002 and displayed until 13/12/2002
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   venlafaxine


© 2009 Datapharm Communications Ltd

Go to www.medicines.org.uk